Experimental cancer cell therapy trial halted after just one patient
Disease control
Terminated
This early-stage study tested a new cell therapy called ITIL-306 for people with advanced solid tumors (ovarian, lung, or kidney cancer) that had stopped responding to standard treatments. The therapy used a patient's own immune cells, modified to better attack cancer cells. Howe…
Phase: PHASE1 • Sponsor: Instil Bio • Aim: Disease control
Last updated May 04, 2026 16:21 UTC